Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine
The article reviews scientific literature on C3435T polymorphism in the ABCB1 gene which encodes P-glycoprotein (an ATP-binding cassette transporter which is responsible for energy-dependent transport of substrates across cellular membranes and whose primary role consists in the prevention of penetr...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
OOO “Vashe Tsifrovoe Izdatelstvo”
2018-02-01
|
Series: | Ведомости Научного центра экспертизы средств медицинского применения |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/143 |
id |
doaj-3c1f621f3d514346b051cdcaecae239c |
---|---|
record_format |
Article |
spelling |
doaj-3c1f621f3d514346b051cdcaecae239c2021-07-28T14:04:08ZrusOOO “Vashe Tsifrovoe Izdatelstvo”Ведомости Научного центра экспертизы средств медицинского применения1991-29192619-11722018-02-0174212220141Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicineR. E. Kazakov0V. A. Evteev1O. V. Muslimova2I. A. Mazerkina3E. Yu. Demchenkova4E. V. Shikh5Scientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsScientific Centre for Expert Evaluation of Medicinal ProductsThe article reviews scientific literature on C3435T polymorphism in the ABCB1 gene which encodes P-glycoprotein (an ATP-binding cassette transporter which is responsible for energy-dependent transport of substrates across cellular membranes and whose primary role consists in the prevention of penetration of various substances, such as xenobiotics, through biological barriers. C3435T polymorphism in the ABCB1 gene could be regarded as a promising pharmacogenetic biomarker which could be used in diagnostic testing after approval of the corresponding test methods. The authors of the article collected and systematized scientific data available in the electronic media (NCBI PubMed, eLIBRARY.ru) regarding medicines (such as digoxin, fexofenadine, loperamide, amlodipine, statins, etc.) for which there are integrated pharmacogenetic data on the effect of C3435T polymorphism in the ABCB1 gene on pharmacokinetic parameters, as well as on the efficacy and safety of treatment. It was demonstrated that ABCB1 gene polymorphism is of great importance for personalised medicine, however, there is a lack of awareness about all the factors that affect the bioavailability of medicines, and this precludes a significant progress in the use of ABCB1 genotyping in the near future.https://www.vedomostincesmp.ru/jour/article/view/143персонализированная медицинагенетический полиморфизмp-гликопротеиноднонуклеотидные полиморфизмыатф-связывающие кассетные транспортерыpersonalised medicinegenetic polymorphismp-glycoproteinsingle nucleotide polymorphismsatp-binding cassette transporters |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
R. E. Kazakov V. A. Evteev O. V. Muslimova I. A. Mazerkina E. Yu. Demchenkova E. V. Shikh |
spellingShingle |
R. E. Kazakov V. A. Evteev O. V. Muslimova I. A. Mazerkina E. Yu. Demchenkova E. V. Shikh Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine Ведомости Научного центра экспертизы средств медицинского применения персонализированная медицина генетический полиморфизм p-гликопротеин однонуклеотидные полиморфизмы атф-связывающие кассетные транспортеры personalised medicine genetic polymorphism p-glycoprotein single nucleotide polymorphisms atp-binding cassette transporters |
author_facet |
R. E. Kazakov V. A. Evteev O. V. Muslimova I. A. Mazerkina E. Yu. Demchenkova E. V. Shikh |
author_sort |
R. E. Kazakov |
title |
Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine |
title_short |
Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine |
title_full |
Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine |
title_fullStr |
Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine |
title_full_unstemmed |
Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine |
title_sort |
prospects of using c3435t polymorphism in the <i>abcb1</i> gene encoding p-glycoprotein in personalised medicine |
publisher |
OOO “Vashe Tsifrovoe Izdatelstvo” |
series |
Ведомости Научного центра экспертизы средств медицинского применения |
issn |
1991-2919 2619-1172 |
publishDate |
2018-02-01 |
description |
The article reviews scientific literature on C3435T polymorphism in the ABCB1 gene which encodes P-glycoprotein (an ATP-binding cassette transporter which is responsible for energy-dependent transport of substrates across cellular membranes and whose primary role consists in the prevention of penetration of various substances, such as xenobiotics, through biological barriers. C3435T polymorphism in the ABCB1 gene could be regarded as a promising pharmacogenetic biomarker which could be used in diagnostic testing after approval of the corresponding test methods. The authors of the article collected and systematized scientific data available in the electronic media (NCBI PubMed, eLIBRARY.ru) regarding medicines (such as digoxin, fexofenadine, loperamide, amlodipine, statins, etc.) for which there are integrated pharmacogenetic data on the effect of C3435T polymorphism in the ABCB1 gene on pharmacokinetic parameters, as well as on the efficacy and safety of treatment. It was demonstrated that ABCB1 gene polymorphism is of great importance for personalised medicine, however, there is a lack of awareness about all the factors that affect the bioavailability of medicines, and this precludes a significant progress in the use of ABCB1 genotyping in the near future. |
topic |
персонализированная медицина генетический полиморфизм p-гликопротеин однонуклеотидные полиморфизмы атф-связывающие кассетные транспортеры personalised medicine genetic polymorphism p-glycoprotein single nucleotide polymorphisms atp-binding cassette transporters |
url |
https://www.vedomostincesmp.ru/jour/article/view/143 |
work_keys_str_mv |
AT rekazakov prospectsofusingc3435tpolymorphismintheiabcb1igeneencodingpglycoproteininpersonalisedmedicine AT vaevteev prospectsofusingc3435tpolymorphismintheiabcb1igeneencodingpglycoproteininpersonalisedmedicine AT ovmuslimova prospectsofusingc3435tpolymorphismintheiabcb1igeneencodingpglycoproteininpersonalisedmedicine AT iamazerkina prospectsofusingc3435tpolymorphismintheiabcb1igeneencodingpglycoproteininpersonalisedmedicine AT eyudemchenkova prospectsofusingc3435tpolymorphismintheiabcb1igeneencodingpglycoproteininpersonalisedmedicine AT evshikh prospectsofusingc3435tpolymorphismintheiabcb1igeneencodingpglycoproteininpersonalisedmedicine |
_version_ |
1721268573398106112 |